Kirkland Reps Baxter International In $380M Baxa Buy

Law360, New York (August 25, 2011, 12:25 PM EDT) -- Baxter International Inc. announced Thursday that it had reached an agreement to purchase Baxa Corp., which develops oral and intravenous drug delivery systems, for $380 million.

Baxter said that accounting and other expenses for the all-cash transaction would cause a temporary drag of 3 to 5 cents per share on its fiscal 2012 earnings, but that the deal would be a net boon to its share price in 2013 and beyond.

Englewood, Colo.-based Baxa specializes in products that improve the efficiency and accuracy of IV and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.